Extremely elevated serum CA125 and CA19-9 levels following the rupture of ovarian endometrioma: A case report
Abstract
Keywords
References
- 1. Bast RCJ, Feeney M, Lazarus H. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331---37
- 2. Ohshio G, Yamaki K, Imamura T, Suwa H, Chang CY, Wada H, et al. Distribution of the carbohydrate antigens, DU-PAN- 2 and CA19-9, in tumors of the lung. Tumori 1995;81:67---73
- 3. Del Villano BC, Brennam S, Brock P, Bucher C, Liu V, McClure M, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19-9. Clin Chem 1983;29:549---52
- 4. Johansson J, Santala M, Kauppila A. Explosive rise of serum CA 125 following the rupture of ovarian endometrioma. Hum Reprod 1998;13:3503---4
- 5. Kashyap RJ. Extremely elevated serum CA125 due to endometriosis. Aust New Zealand J Obstet Gynaecol 1999;39:269---70
- 6. Kammerer-Doak DN, Magrina JE, Nemiro JS, Lidner TK
- Benign gynecologic conditions associated with a CA-125 level > 1000 U/ml. A case report. J Reprod Med 1996;41:179---82
- 7. Guerriero S, Ajossa S, Caffiero A, Mais V. Relationship between abnormally high levels of plasma CA 125 and resolution of acute pelvic pain in two women with endometrioma. Gynecol Obstet Invest 1995;40:61---3
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Authors
Hüseyin Cengiz
This is me
Şükrü Yıldız
This is me
Levent Yaşar
This is me
Murat Ekin
This is me
Cihan Kaya
This is me
Publication Date
April 1, 2012
Submission Date
August 16, 2014
Acceptance Date
-
Published in Issue
Year 2012 Volume: 18 Number: 3